相似文献
1
Drug Metabolism and Toxicological Mechanisms.
Toxics. 2025 May 31;13(6):464. doi: 10.3390/toxics13060464.
2
Evidence-based toxicology: a comprehensive framework for causation.
Hum Exp Toxicol. 2005 Apr;24(4):161-201. doi: 10.1191/0960327105ht517oa.
3
Nitazenes: review of comparative pharmacology and antagonist action.
Clin Toxicol (Phila). 2025 Jun;63(6):393-406. doi: 10.1080/15563650.2025.2504133. Epub 2025 May 27.
4
Toxicology and safety pharmacology investigations on the nervous system: 2024 industry survey.
J Pharmacol Toxicol Methods. 2025 Sep;135:108378. doi: 10.1016/j.vascn.2025.108378. Epub 2025 Jun 23.
5
A global epidemiological perspective on the toxicology of drug-facilitated sexual assault: A systematic review.
J Forensic Leg Med. 2017 Apr;47:46-54. doi: 10.1016/j.jflm.2017.02.005. Epub 2017 Feb 20.
6
A systematic review of pharmacokinetic studies on herbal drug Fuzi: Implications for Fuzi as personalized medicine.
Phytomedicine. 2018 May 15;44:187-203. doi: 10.1016/j.phymed.2018.03.001. Epub 2018 Mar 1.
7
Botany, traditional usages, phytochemistry, pharmacology, and toxicology of Guilandina bonduc L.: a systematic review.
Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):2747-2775. doi: 10.1007/s00210-023-02822-w. Epub 2023 Nov 21.
8
Traditional processing, uses, phytochemistry, pharmacology and toxicology of Aconitum sinomontanum Nakai: A comprehensive review.
J Ethnopharmacol. 2022 Jul 15;293:115317. doi: 10.1016/j.jep.2022.115317. Epub 2022 Apr 22.
9
Current practices on the measurement of electrocardiogram and hemodynamic parameters in non-rodent species in regulatory safety assessment studies.
J Pharmacol Toxicol Methods. 2025 Jun 19;135:107765. doi: 10.1016/j.vascn.2025.107765.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
本文引用的文献
1
Toosendanin-induced liver damage through irreparable DNA damage and autophagy flow blockade.
Phytomedicine. 2025 May;140:156586. doi: 10.1016/j.phymed.2025.156586. Epub 2025 Feb 27.
2
Three-Dimensional Cell Cultures as a Feasible and Promising Alternative to Two-Dimensional and Animal Models in Cancer Research.
Int J Biol Sci. 2024 Sep 30;20(13):5293-5311. doi: 10.7150/ijbs.96469. eCollection 2024.
3
scGPT: toward building a foundation model for single-cell multi-omics using generative AI.
Nat Methods. 2024 Aug;21(8):1470-1480. doi: 10.1038/s41592-024-02201-0. Epub 2024 Feb 26.
4
The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure.
Drug Metab Rev. 2024 Feb;56(1):1-30. doi: 10.1080/03602532.2023.2297154. Epub 2024 Jan 10.
5
Physiologically Based Pharmacokinetic Modeling of Bergamottin and 6,7-Dihydroxybergamottin to Describe CYP3A4 Mediated Grapefruit-Drug Interactions.
Clin Pharmacol Ther. 2023 Aug;114(2):470-482. doi: 10.1002/cpt.2968. Epub 2023 Jun 25.
6
Oxidation and Antioxidation of Natural Products in the Model Organism .
Antioxidants (Basel). 2022 Apr 2;11(4):705. doi: 10.3390/antiox11040705.
7
Assessment of Drug-Induced Toxicity Biomarkers in the Brain Microphysiological System (MPS) Using Targeted and Untargeted Molecular Profiling.
Front Big Data. 2019 Jun 26;2:23. doi: 10.3389/fdata.2019.00023. eCollection 2019.
8
Development and Regulatory Challenges for Peptide Therapeutics.
Int J Toxicol. 2021 Mar-Apr;40(2):108-124. doi: 10.1177/1091581820977846. Epub 2020 Dec 17.
9
Differential Effects of 1α,25-Dihydroxyvitamin D on the Expressions and Functions of Hepatic CYP and UGT Enzymes and Its Pharmacokinetic Consequences In Vivo.
Pharmaceutics. 2020 Nov 23;12(11):1129. doi: 10.3390/pharmaceutics12111129.
10
Pharmacological Aspects of Over-the-Counter Opioid Drugs Misuse.
Molecules. 2020 Aug 27;25(17):3905. doi: 10.3390/molecules25173905.
Zotero 插件